EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Conversion to LCP Tacrolimus Mitigates Calcineurin‐Induced Nephrotoxicity in Patients After Liver Transplantation

Maximilian Joseph Brol iD, Isabella Munske, Iyad Kabar iD, Philipp Stephan Althaus iD, Wenyi Gu iD, Frank Erhard Uschner iD, Michael Praktiknjo iD, Martin Sebastian McCoy, Kai-Henrik Peiffer iD, Florian Rennebaum, Philipp Houben iD, Andreas Pascher iD und 4 weitere

Clinical Transplantation · 2026-06 · 40 (6)

DOI: 10.1111/ctr.70602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, online erschienen am 23.06.2026. Verfasst von Maximilian Joseph Brol und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine B, University Hospital Münster, Münster, Germany. Hauptthemen laut MEDLINE: Tacrolimus, Liver Transplantation, Calcineurin Inhibitors, Graft Rejection. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Horizon 2020 Framework Programme, Eurostars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Calcineurin inhibitor (CNI)‐induced nephrotoxicity after liver transplantation (LT) is linked to increased morbidity and mortality. LCPT offers a particular extended‐release formulation, potentially improving the concentration‐dose (C/D) ratio and renal outcomes. This study investigated the impact of switching from standard‐release Tacrolimus (SR‐Tac) to LCPT on C/D ratio and renal function.

Methods

170 adult LT recipients (August 2008–March 2020) treated with tacrolimus for at least two years were included. In this single‐center, retrospective analysis, 63 patients converted to LCPT, while 107 patients continued on SR‐Tac. Clinical data were collected every three months over 24 months.

Results

At baseline, median C/D ratios were similar between groups ( p = 0.553), the LCPT group showed significantly higher C/D ratios compared to SR‐Tac during both the first ( p = 0.003) and second year ( p = 0.004). While LCPT‐treated patients showed an increased mean estimated glomerular filtration rate (eGFR), the SR‐Tac group exhibited a progressive decline at each follow‐up (mean decline: −5.4 mL/min/1.73m 2 at 24 months, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusLiver TransplantationCalcineurin InhibitorsGraft RejectionPostoperative ComplicationsKidney DiseasesHumansFemaleMaleRetrospective StudiesMiddle AgedImmunosuppressive AgentsFollow-Up StudiesGlomerular Filtration RatePrognosisGraft SurvivalKidney Function TestsRisk FactorsAdult

Stichwörter der Autor:innen

CD‐ratioLCPTkidney functionliver transplantationnephrotoxicitytacrolimusrenal function

Substanzen

TacrolimusImmunosuppressive AgentsCalcineurin Inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine B, University Hospital Münster, Münster, Germany.
  • Department of General, Visceral and Transplant Surgery, University Hospital Münster, Münster, Germany.
  • Department of Hepatology, Gastroenterology and Transplantation Medicine, University Hospital Essen, Essen, Germany.
  • European Foundation for the Study of Chronic Liver Failure-EF Clif, Barcelona, Spain.

ORCID-Profile: Maximilian Joseph Brol, Iyad Kabar, Philipp Stephan Althaus, Wenyi Gu, Frank Erhard Uschner, Michael Praktiknjo, Kai-Henrik Peiffer, Philipp Houben, Andreas Pascher, Hartmut H Schmidt, Jonel Trebicka

Förderung

  • Deutsche Forschungsgemeinschaft
  • Horizon 2020 Framework Programme
  • Eurostars
  • Hessisches Ministerium für Wissenschaft und Kunst
  • Bundesministerium für Bildung und Forschung

Zitieren

APA

Brol, M. J., Munske, I., Kabar, I., Althaus, P. S., Gu, W., Uschner, F. E., Praktiknjo, M., McCoy, M. S., Peiffer, K. H., Rennebaum, F., Houben, P., Pascher, A., Schmidt, H. H., Trebicka, J., Schomacher, T., & Hüsing-Kabar, A. (2026). Conversion to LCP Tacrolimus Mitigates Calcineurin‐Induced Nephrotoxicity in Patients After Liver Transplantation. Clinical Transplantation, 40(6). https://doi.org/10.1111/ctr.70602

Vancouver

Brol MJ, Munske I, Kabar I, Althaus PS, Gu W, Uschner FE, et al. Conversion to LCP Tacrolimus Mitigates Calcineurin‐Induced Nephrotoxicity in Patients After Liver Transplantation. Clinical Transplantation. 2026;40(6). doi:10.1111/ctr.70602

BibTeX
@article{Brol2026,
  author = {Brol, Maximilian Joseph and Munske, Isabella and Kabar, Iyad and Althaus, Philipp Stephan and Gu, Wenyi and Uschner, Frank Erhard and Praktiknjo, Michael and McCoy, Martin Sebastian and Peiffer, Kai-Henrik and Rennebaum, Florian and Houben, Philipp and Pascher, Andreas and Schmidt, Hartmut H and Trebicka, Jonel and Schomacher, Tina and Hüsing-Kabar, Anna},
  title = {Conversion to LCP Tacrolimus Mitigates Calcineurin‐Induced Nephrotoxicity in Patients After Liver Transplantation},
  journal = {Clinical Transplantation},
  year = {2026},
  volume = {40},
  number = {6},
  doi = {10.1111/ctr.70602}
}
Kostenlos starten →